FibroGen (United States)

267 papers and 17.7k indexed citations i.

About

In recent decades, authors affiliated with FibroGen (United States) have published 267 papers, which have received a total of 17.7k indexed citations. Scholars at this organization have produced 129 papers in Molecular Biology, 63 papers in Cancer Research and 53 papers in Hematology on the topics of Connective Tissue Growth Factor Research (82 papers), Cancer, Hypoxia, and Metabolism (46 papers) and Erythropoietin and Anemia Treatment (41 papers). Their work is cited by papers focused on Molecular Biology (9.0k citations), Cancer Research (4.1k citations) and Genetics (2.3k citations). Authors at FibroGen (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry. Some of FibroGen (United States)'s most productive authors include Andrew Leask, David R. Olsen, Volkmar Günzler, Johanna Myllyharju, Kari I. Kivirikko, Peppi Koivunen, Kenneth E. Lipson, Maija Hirsilä, David Abraham and Suzanne Spong.

In The Last Decade

Fields of papers published by authors at FibroGen (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with FibroGen (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with FibroGen (United States) at the time of their publication.

Countries citing scholars working at FibroGen (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at FibroGen (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at FibroGen (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FibroGen (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact